We have conducted a retrospective, cross-sectional study with the aim to explore the mechanistic role of the myokine irisin in a population of biopsy-established NAFLD, in the absence of major metabolic burdens (obesity and T2DM). This evidence concerns the gene FNDC5 and type 2 diabetes mellitus.